A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD
Clinical trial NCT06488313 · RECRUITING
Trial details
- NCT number
- NCT06488313
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2026-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.